Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

Fig. 5

Comparison of myelotoxicity and gastrointestinal toxicity between Endostar combined with chemotherapeutic agents versus chemotherapeutic agents alone through thoracic perfusion for treating MPE. a Comparison of myelotoxicity between Endostar combined with chemotherapeutic agents versus chemotherapeutic agents alone; b Comparison of gastrointestinal toxicity between Endostar combined with chemotherapeutic agents versus chemotherapeutic agents alone; OR = odds ratio; MPE, malignant pleural effusions

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us